American International Group, Inc. Vista Gen Therapeutics, Inc. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.12 - $0.3 $238 - $596	1,989 Added 2.03%	99,879 $11,000
Q4 2022 Feb 10, 2023	BUY	$0.09 - $0.16 $489 - $870	5,439 Added 5.88%	97,890 $9,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.07 $182 - $1,396	1,305 Added 1.43%	92,451 $14,000
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.73 $4,564 - $8,973	-5,187 Reduced 5.38%	91,146 $80,000
Q1 2022 May 13, 2022	SELL	$1.14 - $2.09 $7,730 - $14,172	-6,781 Reduced 6.58%	96,333 $119,000

Q4 2021 Feb 11, 2022	SELL	$1.67 - $2.76 $5,150 - $8,511	-3,084 Reduced 2.9%	103,114 $201,000
Q3 2021 Nov 12, 2021	SELL	$2.62 - $3.45 $2,622 - $3,453	-1,001 Reduced 0.93%	106,198 $291,000
Q2 2021 Aug 13, 2021	BUY	$1.96 - $3.15 $210,110 - $337,676	107,199 New	107,199 $338,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.